You are here

obesity

EU regulator backs use of Novo's Wegovy for obesity-related heart condition

Reuters

Thu, 09/19/24 - 09:16 pm

heart failure with preserved ejection fraction

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

CNBC

Thu, 09/19/24 - 11:13 am

Obesity pill race heats up as Novo, Roche and Terns share data

BioSpace

Tue, 09/17/24 - 11:22 am

Terns Pharmaceuticals

clinical trials

‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day

Fierce Biotech

Wed, 09/11/24 - 11:15 pm

Carmot Therapeutics

Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial

Fierce Biotech

Wed, 09/11/24 - 11:53 am

clinical trials

Study backs role of Novo Nordisk obesity drug in children

Pharmaphorum

Wed, 09/11/24 - 11:36 am

clinical trials

Immunis receives FDA clearance for Phase II sarcopenic obesity therapy trial

Clinical Trials Arena

Wed, 09/11/24 - 11:22 am

clinical trials

sarcopenic obesity

Weight-loss market to see 16 new drugs by 2029, report estimates

Reuters

Tue, 09/10/24 - 04:29 pm

Boehinger Ingelheim

Structure Therapeutics

Viking Therapeutics

Terns Pharmaceuticals' oral obesity drug shows promise in early study, shares jump

Reuters

Mon, 09/9/24 - 11:29 am

Terns Pharmaceuticals

clinical trials

OrsoBio Announces Oversubscribed $67 Million Series B Financing to Accelerate Mitochondrial Protonophore Portfolio Targeting Obesity and Associated Disorders

Businesswire

Fri, 09/6/24 - 10:50 am

57 Million Eligible For GLP-1 Drug Coverage In U.S. And That’s Just Those Under 65

Forbes

Thu, 09/5/24 - 10:29 pm

Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases

BioSpace

Thu, 09/5/24 - 11:40 am

BioAge files for IPO, plans pair of midstage obesity trials

Fierce Biotech

Wed, 09/4/24 - 11:40 am

clinical trials

Eli Lilly bets $1B in biobucks on Haya to scour dark genome for obesity targets

Fierce Biotech

Wed, 09/4/24 - 11:37 am

Haya Therapeutics

New research could ease concerns over suicide risk of obesity drugs

BioPharma Dive

Tue, 09/3/24 - 05:58 pm

Novo builds heart failure case for semaglutide

BioPharma Dive

Fri, 08/30/24 - 11:31 am

cardiovascular disease

Ambrosia lands $16m to ‘improve on existing GLP-1 drugs’

Longevity Technology

Wed, 08/21/24 - 11:26 am

Ambrosia Biosciences

Array Biopharma

Forget Mounjaro: Eli Lilly's Next Big Blockbuster Has Arrived

Motley Fool

Sun, 08/18/24 - 09:19 pm

After clearing out heart disease drug, Arrowhead maps out obesity development plans

Fierce Biotech

Wed, 08/14/24 - 10:41 pm

Arrowhead Pharmaceuticals

5 Obesity Readouts to Watch in the Second Half of 2024

BioSpace

Tue, 08/13/24 - 11:47 am

clinical trials

Terns Pharmaceuticals

Pages